Article By:
Terry Chrisomalis
Friday, May 3, 2019 8:04 AM EDT
TOMDF is a diagnostics company that utilizes blood tests for early detection of cancer and neurodegenerative diseases. But is it a good investment? I took a deeper look and reached out to the company's CEO, Herman Weiss, to get the facts.
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
Good article. Holding both $CYDY & $TOMDF
Finally A Real Cancer Diagnosis Breakthrough?
This sounds very encouraging. I'll be keeping an eye on $TOMDF.
Finally A Real Cancer Diagnosis Breakthrough?
That's wonderful! Congrats to $TOMDF
Finally A Real Cancer Diagnosis Breakthrough?
As a socially responsible investor, this company is very appealing. $TOMDF
Finally A Real Cancer Diagnosis Breakthrough?
That's what I was thinking. Maybe I don't understand the science well enough, but this sounds like a pretty big deal. Why isn't $TOMDF shooting up like a rocket? What am I missing? Been trying to find more info but it doesn't look like many sites cover this stock.
Finally A Real Cancer Diagnosis Breakthrough?
Sounds like some big news for #TodosMedical and #AmarantusBiosciences today. Very promising. Can anyone weigh in if this science is as much of a breakthrough in cancer diagnosis as it sounds? $TOMDF $AMBS
Finally A Real Cancer Diagnosis Breakthrough?
This is very impressive news about $TOMDF. In fact it almost sounds TOO good to be true. A better, cheaper test that save more lives? Are there any downsides? Is it just as accurate as existing tests?